Released Feb 26, 2026, after the close
10-K filed Feb 26, 2026, 57 days after period end · 0001437749-26-005910
Q4 2025 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$386.51M$386.51M derived+4.6% vs Q4 2024+1.0% vs Q3 2025
Net Income$24.85M$24.85M derived+308.6% vs Q4 2024−36.7% vs Q3 2025
EPS, diluted—Not derived. Share counts vary by quarter.
Operating Incomederived$33,117,000+14.5%
Operating Cash Flowderived$16,807,000+31.4%
Free Cash Flowderived$6,410,000+38.4%
Margins · derived
Operating margin8.6%+0.7 pt vs Q4 2024
Net margin6.4%+4.8 pt vs Q4 2024
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-K.
Same quarter
| Metric | Q4 2025dderived from reported figures | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures |
|---|---|---|---|---|
| Revenue | $386.51M | $369.35M | $300.91M | $264.55M |
| Net Income | $24.85M | $6.08M | $28.41M | $6.35M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
National Healthcare Corp · CIK 1047335 · Engraved from SEC EDGAR